Tags:DevelopmentPlatform
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
Total raised: $96.6M

Investors 3

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
04.04.2018Series C$55M-Arvinas Co...
21.10.2015Series B$41.6M-Arvinas Cl...

Mentions in press and media 8

DateTitleDescriptionCategoryAuthorSource
09.04.2018The biotec...Julie Papanek Grant, a partner...--medcitynew...
05.04.2018Term Sheet...GOT MONEY Good morning, Term ...--fortune.co...
04.04.2018Arvinas Co...Arvinas, LLC, a New Haven, Con...USA-finsmes.co...
04.04.2018Arvinas Co...Arvinas LLC, a private biotech...--citybizlis...
04.01.2018Pfizer and...So what’s attracting the big...--medcitynew...
21.10.2015Arvinas Cl...Arvinas LLC, a New Haven, CT-b...USA-finsmes.co...
21.10.2015Arvinas ra...Arvinas’ science comes from ...--medcitynew...
16.10.2014Venture fi...The company’s had a dozen ex...--medcitynew...